Chiesi Farmaceutici is an Italian company headquartered in Parma and founded in 1935 by Giacomo Chiesi, now run by the third generation of the Chiesi family and one of the largest unlisted European pharma companies. The company focuses on respiratory medicine, rare diseases and neonatology.
Its Trimbow combination inhaler is among the most-prescribed COPD treatments in Europe, and Chiesi is a certified B Corp.